Dynamic Ontology-Based Sensor Binding

Pascal Hirmer,Matthias Wieland,Uwe Breitenbücher,B. Mitschang

DOI: https://doi.org/10.1007/978-3-319-44039-2_22

2016-08-28

Abstract:

What problem does this paper attempt to address?

Impact of tricuspid regurgitation on right ventricular function and clinical outcomes in pulmonary arterial hypertension: food for thought

Thenappan Thenappan

DOI: https://doi.org/10.1183/13993003.00797-2024

IF: 24.3

2024-06-21

European Respiratory Journal

Abstract:Extract Right ventricular (RV) function is the linchpin in the natural history of pulmonary arterial hypertension (PAH) [1]. Patients with PAH feel well, function better and live longer if RV function is preserved [1]. The RV initially adapts to the increased afterload in the pulmonary circulation by hypertrophy and increased contractility, which maintains stroke volume. This is called the homeometric adaptation or the Anrep effect [1]. Eventually when the homeometric adaption is not enough to maintain cardiac output, the RV dilates, which maintains stroke volume by increasing the RV end-diastolic volume based on the Starling principle, which is referred to as the heterometric adaption [1]. Progressive RV dilation can lead to dilatation of the tricuspid valve annulus, malcoaptation of the tricuspid valve leaflets, and ultimately tricuspid regurgitation [2].

respiratory system
Right ventricular systolic function in severe tricuspid regurgitation: prognostic relevance of longitudinal strain

Francesco Ancona,Francesco Melillo,Francesco Calvo,Nadia Attalla El Halabieh,Stefano Stella,Cristina Capogrosso,Giacomo Ingallina,Elvin Tafciu,Antonia Pascaretta,Marco Bruno Ancona,Michele De Bonis,Alessandro Castiglioni,Paolo Denti,Matteo Montorfano,Azeem Latib,Antonio Colombo,Ottavio Alfieri,Eustachio Agricola

DOI: https://doi.org/10.1093/ehjci/jeab030

2021-07-20

Abstract:Aims: The aim of this study is to analyse the prognostic implications of right ventricular (RV) dysfunction as detected by strain analysis in patients with severe tricuspid regurgitation (TR). The evaluation of RV systolic function in presence of severe TR is of paramount importance for operative risk stratification; however, it remains challenging, as conventional echocardiographic indexes usually lead to overestimation. Methods and results: We enrolled 250 consecutive patients with severe TR referred to our centre. Baseline clinical and echocardiographic data and follow-up outcomes were collected. Patients were predominantly female, with multiple cardiovascular risk factors and comorbidities, history of heart failure, and atrial fibrillation. Most of them had presented with clinical signs of RV heart failure (RVHF) and advanced New York Heart Association class. The RV strain analysis [both RV free wall longitudinal strain (RVFWLS) and RV global longitudinal strain (RVGLS)] reclassified ∼42-56% of patients with normal RV systolic function according to conventional parameters in patients with impaired RV systolic function. RVFWLS ≤17% (absolute values, AUC: 0.66, P = 0.002) predicted the presence of RVHF [odds ratio (OR) 0.93, P = 0.01]. At follow-up, patients with RVFWLS >14% (absolute values, AUC: 0.70, P = 0.001, sensitivity 72%, specificity 54%) showed a better survival (P = 0.01). Conclusion: Different ranges of RVFWLS have different implications in patients with severe TR, allowing to identify a preclinical and a clinical window, with correlations to RVHF and survival.
Right ventricular function in moderate-to-severe ventricular tricuspid regurgitation: Is there a pseudo-normalization of conventional echocardiographic parameters?

A Schmeisser,T Rauwolf,T Groscheck,I Tanev,S Meissler,M Hansen,B Luani,T Bekfani,P Steendijk,R U E D I G Braun-Dullaeus

DOI: https://doi.org/10.1093/eurheartj/ehad655.1761

IF: 39.3

2023-11-01

European Heart Journal

Abstract:Abstract Background A reliable evaluation of right ventricular (RV) function in the presence of moderate-to-severe tricuspid regurgitation (m/s-TR) is of paramount importance for surgical or interventional risk stratification. Due to the significant systolic regurgitation of blood from the RV to the low-pressure right atrium, conventional echocardiographic parameters could appear normal and thus overestimate RV function (pseudo-normal). The aim of this study was to analyse and compare RV function in trace TR versus m/s-TR by the invasive pressure-volume-loop (PV-loop) technique, the gold standard of RV function analysis, with conventional echocardiographic indices in patients with the ventricular form of mild/no vs. m/s-TR. Methods The study was conducted in 134 patients with HFrEF in a post-hoc analysis (110 from the Magdeburg CRT Responder Trial, and 24 from a local CRT-optimization trial). Results The logistic regression analysis demonstrated that RV size (RV-end-diastolic volume, RVEDV) and RV function (measured as RV fractional area change, FAC), TAPSE, and lower fractional shortening (FS) of proximal the RV-outflow tract (RVOTprox) was closely associated with PV-loop-derived RV total afterload (pulmonary arterial elastance, Ea) and coupling of RV contractility (end-systolic RV elastance, Ees) to Ea (Ees/Ea) (all, p<0.001). Compared to trace TR (n=98, 73%), m/s-TR (n=36, 27%) was accompanied with significant higher total afterloads (Ea: 0.75 vs.0.41, p<0.001) and lower RV-PA coupling ratios (Ees/Ea, 0.4 vs. 0.79, p<0.001). This was associated with enlarged RVs (RVEDV: 210ml vs. 166ml), lower FAC (31% vs. 50%), TAPSE (13mm vs. 18mm), and RVOTprox (22% vs. 39%) (all p<0.001). For better comparability between trace TR and m/s-TR tertiles (T1-T3) of similar afterloads (Ea) were formed. The m/s-TR patients showed significant lower RV-PA coupling ratios than trace TR at the lower two Ea tertiles T1 (p=0.034) and T2 (p<0.001). At Ea T3 the difference was no longer significant (p=0.055). The hemodynamic data are mirrored by significant lower FACs, FS RVOTprox, and TAPSE at T1 and T2 (all p<0.05), and a nonsignificant difference at T3 in m/s-TR. In conclusion: In our cohort of HFrEF patients, echocardiographic RV function reflects very closely the hemodynamic coupling efficiency of RV contractility (Ees) to afterload (Ea) and seems independent from the extent of TR. We found no evidence for pseudo-normal or overestimated echocardiographic RV function in m/s-TR.

cardiac & cardiovascular systems
Prognostic Implications of Right Ventricular Remodeling and Function in Patients With Significant Secondary Tricuspid Regurgitation

Marlieke F Dietz,Edgard A Prihadi,Pieter van der Bijl,Laurien Goedemans,Bart J A Mertens,Erhan Gursoy,Olton S van Genderen,Nina Ajmone Marsan,Victoria Delgado,Jeroen J Bax

DOI: https://doi.org/10.1161/CIRCULATIONAHA.119.039630

IF: 37.8

2019-09-09

Circulation

Abstract:Background: In patients with significant (moderate and severe) tricuspid regurgitation (TR), the decision to intervene is influenced by right ventricular (RV) size and function. RV remodeling in significant secondary TR has been underexplored. The aim of this study was to characterize RV remodeling in patients with significant secondary TR and to investigate its prognostic implications. Methods: RV remodeling was characterized by transthoracic echocardiography in 1292 patients with significant secondary TR (median age 71 [62-78]; 50% male). Four patterns of RV remodeling were defined according to the presence of RV dilation (tricuspid annulus≥40 mm) and RV systolic dysfunction (tricuspid annulus systolic excursion plane<17 mm): pattern 1, normal RV size and systolic function; pattern 2, dilated RV with preserved systolic function; pattern 3, normal RV size with systolic dysfunction; and pattern 4, dilated RV systolic dysfunction. The primary end point was all-cause mortality and the event rates were compared across the 4 patterns of RV remodeling. Results: A total of 183 (14%) patients showed pattern 1 RV remodeling; 256 (20%) showed pattern 2; 304 (24%) presented with pattern 3; and 549 (43%) had pattern 4 RV remodeling. Patients with pattern 4 RV remodeling were more frequently male; more often had coronary artery disease, worse renal function, and impaired left ventricular ejection fraction; and were more often symptomatic. Only 98 (8%) patients underwent tricuspid valve annuloplasty during follow-up. During a median follow-up of 34 (interquartile range, 0-60) months, 510 (40%) patients died. The 5-year survival rate was significantly worse in patients presenting with patterns 3 and 4 RV remodeling in comparison with pattern 1 (52% and 49% versus 70%; P=0.002 and P<0.001, respectively), and were independently associated with poor outcome on multivariable analysis. Conclusions: In patients with significant secondary TR, patients with RV systolic dysfunction have worse clinical outcome regardless of the presence of RV dilation.
Prognostic value of right atrial function in patients with significant tricuspid regurgitation

Takahiro Nishihara,Yoichi Takaya,Rie Nakayama,Yu Yoshida,Norihisa Toh,Toru Miyoshi,Kazufumi Nakamura,Shinsuke Yuasa

DOI: https://doi.org/10.1002/ehf2.14846

2024-08-02

Abstract:Aims: Although right ventricular (RV) dysfunction is associated with adverse outcomes in tricuspid regurgitation (TR), the potential role of right atrial (RA) function is unknown. We aimed to investigate the relationship between RA function and clinical outcomes in patients with significant TR. Methods: This retrospective study included 169 outpatients with moderate or severe TR due to left-sided heart diseases who underwent transthoracic echocardiography between June 2020 and April 2023 (average age, 75 ± 10 years; male, 40%). Patients with atrial fibrillation were excluded from this study due to the inaccuracy of the evaluation using 2D speckle-tracking echocardiography. RA function was compared between patients with and without events, which were defined as all-cause mortality or hospitalization due to heart failure. RA function was calculated as RA global longitudinal strain (RAGLS) with the 2D speckle-tracking echocardiography. Results: During a median follow-up of 13 months, 19 patients had events (all-cause mortality: 14 cases, hospitalization due to heart failure: 5 cases). RAGLS was lower in patients with events than in those without events (13% ± 10% vs. 18% ± 9%, P = 0.02). When the patients were categorized into two groups [low RAGLS ≤ 16.2% vs. high RAGLS > 16.2%, high RA volume index (RAVI) ≥ 50 mL/m2 vs. low RAVI < 50 mL/m2], Kaplan-Meier curves showed that patients with low RAGLS had higher event rates than those with high RAGLS (log-rank test, P = 0.003). Patients with high RAVI had higher event rates than those with low RAVI (log-rank test, P < 0.001). In the multivariate Cox regression analysis, low RAGLS (≤16.2%) was significantly associated with events in a model that included RV dysfunction (RV fractional area change ≤ 35%) or high RAVI (≥50 mL/m2) (hazard ratio: 4.55, 95% confidence interval: 1.51-13.71, P < 0.01; hazard ratio: 4.57, 95% confidence interval: 1.52-13.79, P < 0.01, respectively). Conclusions: RAGLS is associated with all-cause mortality and hospitalization due to heart failure in patients with significant TR. Our results suggest that RA function is a sensitive marker for identifying the risk stratification of significant TR.
Fractionation of proteins from single neurons of Planorbis corneus by micro-electrophoresis on SDS-gradient polyacrylamide gels.

N. Osborne,R. Rüchel

DOI: https://doi.org/10.1016/S0021-9673(01)81108-0

IF: 4.601

1975-02-19

Journal of Chromatography A

Abstract:
Mechanistic Insights into Tricuspid Regurgitation Secondary to Pulmonary Arterial Hypertension

Nicholas Kassis,Habib Layoun,Amit Goyal,Tiffany Dong,Anas M Saad,Rishi Puri,Brian P Griffin,Gustavo A Heresi,Adriano R Tonelli,Samir R Kapadia,Serge C Harb

DOI: https://doi.org/10.1016/j.amjcard.2022.04.010

2022-07-15

Abstract:The simultaneous presence of pulmonary arterial hypertension (PAH) and secondary tricuspid regurgitation (STR) portends particularly poor outcomes. However, not all patients with PAH develop significant STR, and the mechanisms and clinical implications underlying this phenomenon remain unclear. We sought to describe the functional, anatomic, hemodynamic, and clinical characteristics of patients with PAH with and without STR. Patients diagnosed with PAH between 2007 and 2013 were included. STR, defined by absent primary tricuspid valve disease on transthoracic echocardiogram, was considered significant if ≥ moderate in severity. The characteristics of right-sided chambers and tricuspid valve annuli and leaflets were compared between patients with significant versus nonsignificant STR using a transthoracic echocardiogram, cardiac computed tomography, and right-sided cardiac catheterization. These features were then correlated with the composite outcome of all-cause mortality and PAH hospitalization. Of 88 included patients, 52 had significant STR. No baseline clinical differences, including atrial fibrillation, were observed. Patients with significant STR had worse right ventricular dysfunction (tricuspid annular planar systolic excursion = 1.5 vs 2.1 cm; p = 0.02) and increased right ventricular sphericity (sphericity index = 1.8 vs 2; p = 0.004), with similar annular dimensions/shape, lengths/angles of the mural and septal leaflets, and tenting height. After a median of 54 months, right atrial mean pressure was independently associated with the composite outcome on multivariable analysis (hazard ratio = 1.07, p = 0.02). In conclusion, anatomic and functional alterations in the right ventricle rather than the tricuspid valve are implicated in developing significant STR in PAH. Multimodality imaging provides mechanistic insight, and hemodynamic assessment may offer prognostic guidance in this population.
Mortality and heart failure in patients with severe tricuspid regurgitation. Impact of RV volumes and function by CMR.

R Hinojar Baydes,N Ramos,J Rodriguez Palomares,R Eiros,M Barreiro,M J Calero,S Rodriguez,L Gutierrez,L Galian,C Garcia-Sebastian,J M Monteagudo,A Garcia-Martin,A Gonzalez-Gomez,C Fernandez-Golfin,J L Zamorano

DOI: https://doi.org/10.1093/eurheartj/ehae666.1937

IF: 39.3

2024-10-28

European Heart Journal

Abstract:Background Beyond symptoms, right ventricle (RV) dilatation and dysfunction are established criteria for intervention in patients with significant tricuspid regurgitation (TR); however defined thresholds to support intervention are lacking. As a result, the optimal timing for intervention remains controversial and it is commonly undertaken at a late stage. Purpose To describe prognostic cut-off values of RV size and function by Cardiac Magnetic Resonance in a multicentre cohort of patients with at least severe TR. Methods The study enrolled patients with at least severe TR assessed by 2D echocardiography who underwent a contemporary cardiac magnetic resonance (CMR) study. Conventional parameters of biventricular volume and function were assessed in all patients. A combined endpoint of hospital admission due to heart failure (HF) and all-cause mortality was defined. Results 318 patients with severe TR recruited from 5 tertiary care hospitals were included in this study (70 ± 11 years, 67% female, 73% NYHA I or II). Regarding the etiology, 10% were primary TR, 1% CIED-related TR, 46 % atrial secondary TR and 43% ventricular secondary TR. After a median follow-up of 28 months (IQR: 10-54 months), 42% of the patients (n=134) experienced the combined endpoint (n=113 were admitted due to HF, n=61 died). After adjusting for age, NYHA class, comorbidities, type of TR and LVEF in a multivariate Cox proportional model (LR Chi-Square: 88.01, p<0.001), RV-EDV and RVEF were independently associated with all-cause mortality and heart failure (adjusted HR for RV-EDV per ml/m2 =1.008 [1.005-1.012], p<0.001 and RVEF HR per 1%=0.961 [0.942-0.981], p<0.001). Thresholds of RV-EDV ≥ 93 ml/m2, RV-ESV ≥ 39 ml/m2 and RVEF ≤ 58% held the best accuracy to predict outcomes (figure). In multivariable analysis, prognostic cut-off values of RV-EDV, RV-ESV and RVEF was associated with 1.91, 2.03, and 1.76-fold increased risk of HF or all-cause mortality respectively (RV-EDV HR: 1.91 [1.34-2.71], p<0.001, RV-ESV HR 2.03 [1.42-2.89], p<0.001 and RVEF HR1.76 [1.25-2.49], p=0.001). Conclusion RV size and function are crucial for determining optimal timing for TR intervention. CMR remains the gold standard to assess RV remodeling. Cut-off values of RV volume and function by CMR are defined in a multicentre cohort of patients based on outcome data; proposed thresholds differ from those previously established by echocardiography.Kaplan Meier curves

cardiac & cardiovascular systems
Experimental production of carcinoma with cigarette tar. III. Occurrence of cancer after prolonged latent period following application of tar

E. A. Graham,A. Croninger,E. Wynder

DOI: https://doi.org/10.1002/1097-0142(195705/06)10:3<431::AID-CNCR2820100303>3.0.CO;2-Q

IF: 6.9209

1957-05-01

Cancer

Abstract:HE current interest in the relationship of T cigarette smoking to cancer of the lung often leads the medical profession as well as the laity to wonder and to ask: if a man stops smoking before a cancer has appeared, can he be assured that none will develop later? In other words, has there been demonstrated a lag period after the cessation of the smoking during which a cancer may develop? While we were collecting material for our first statistical study of the relationship of cigarette smoking to the production of broncliogenic carcinoma, published in 1950,4 we saw three among 605 male lung-cancer patients who, although formerly heavy smokers, had stopped smoking ten to fifteen years prior to the development of clinical symptoms of lung cancer. It is well known, OI course, that with some carcinogens such a lag or latent period does exist. For example, it has been established that in the case of contact with some radioactive materials, there are long latent periods before the resultant cancer appears. The Schneeberg miners, whose lung cancers supposedly were due to the inhalation of radon, were said by Schmorl3 to have had a lag of several years-in one case eighteen yearsafter their exposure to the radioactive material before the development of the cancers. Mider and Morton2 reported in 1939 the development of carcinomas in C57 brown mice sixteen to thirty-two weeks after a single application of methylcholanthrene. This would correspond to several years in the human.
Impact of Right Ventricular Dysfunction and Tricuspid Regurgitation on Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement

Lorin Arie Schwartz,Zach Rozenbaum,Ehab Ghantous,Judith Kramarz,Simon Biner,Michael Ghermezi,Jason Shimiaie,Ariel Finkelstein,Shmuel Banai,Galit Aviram,Meirav Ingbir,Gad Keren,Yan Topilsky

DOI: https://doi.org/10.1016/j.echo.2016.08.016

IF: 7.722

2017-01-01

Journal of the American Society of Echocardiography

Abstract:BACKGROUND: Right ventricular (RV) dysfunction and tricuspid regurgitation (TR) may coexist with aortic stenosis. The aim of this study was to assess the association between RV dysfunction, TR, associated comorbidities, and outcomes following transcatheter aortic valve replacement (TAVR).METHODS: A retrospective analysis was conducted of baseline and 6-month clinical and echocardiographic parameters, including TR grade, RV size (grade, end-diastolic and end-systolic areas, annular diameter), and function (grade, tricuspid annular plane systolic excursion [TAPSE], fractional area change, Tei index), in 519 consecutive TAVR patients.RESULTS: The prevalence of moderate or greater TR was 11% (n = 59). Although TR was associated with increased mortality (P = .02) in unadjusted analysis, it did not demonstrate an independent association with outcome when adjusted for RV dysfunction (TAPSE; P = .30) or multiple clinical parameters (P ≥ .20). RV parameters associated with poor outcomes included TAPSE (P = .006) and Tei index (P = .005). TAPSE was associated with lower survival even when adjusted for TR (P = .009) and all clinical parameters (P = .01). Persistence of moderate or greater TR 6 months after TAVR seemed to be associated with lower survival (P = .02), even when adjusted for clinical and RV parameters (P = .07).CONCLUSIONS: TR in association with aortic stenosis is frequently progressive despite TAVR but is not independently associated with outcomes. RV function is a stronger driver of adverse outcomes compared with TR itself, and RV quantitative rather than qualitative evaluation is the key to stratify these patients.

cardiac & cardiovascular systems
Echocardiographic pulmonary vascular resistance in patients undergoing tricuspid annuloplasty: prognostic implications and reversibility

J Zhang,C Y Zhu,K H Yiu

DOI: https://doi.org/10.1093/eurheartj/ehae666.1934

IF: 39.3

2024-10-29

European Heart Journal

Abstract:Background Pulmonary vascular resistance (PVR) intimately connects with right ventricular afterload and the development of secondary tricuspid regurgitation (sTR). Objectives We sought to investigate the prognostic roles of PVR derived from echocardiography in patients who underwent tricuspid annuloplasty (TA) for sTR. Methods Data from 322 patients who underwent TA [median age (interquartile range): 65.0 (59.0-70.0) years; 35.7% males] were obtained from a prospective registry to determine the impact of PVR on the composite outcome (including all-cause mortality and heart failure hospitalization). PVR was calculated by dividing the peak TR velocity by time-velocity integral of the right ventricular outflow tract and then adding 0.16. Results During a median follow-up of 5.2 (interquartile range: 2.2-8.2) years, 108 adverse events occurred including 48 deaths and 60 heart failure readmissions. Baseline PVR ≥ 2.0WU was independently associated with a higher risk of composite outcome (adjusted HR[KY1] [u2] :1.674, 95% CI: 1.028-2.726, P=0.038). Baseline PVR outperforms pulmonary artery systolic pressure (PASP) and the ratio of tricuspid annulus plane systolic excursion to PASP in terms of outcome prediction, with pronounced improvement of global model fit, reclassification, and discrimination. In 150 patients who received echocardiograms after surgery, the presence of post-operative PVR ≥ 2.0WU (n=20, 13.3%) was independently associated with the composite outcome (adjusted HR: 2.621, 95% CI: 1.292-5.319, P=0.008). Conclusion PVR measured on echocardiography is an independent determinant of clinical outcomes in patients undergoing TA. The inclusion of echocardiographic PVR assessment may provide valuable additional information for patient selection and risk stratification in this population.Kaplan-Meier CurveChange of PVR after Surgery

cardiac & cardiovascular systems
Right Heart Remodeling and Outcomes in Patients With Tricuspid Regurgitation

Sara Bombace,Federico Fortuni,Giacomo Viggiani,Maria Chiara Meucci,Gianluigi Condorelli,Erberto Carluccio,Maximilian von Roeder,Alexander Jobs,Holger Thiele,Giovanni Esposito,Philipp Lurz,Paul A Grayburn,Anna Sannino,Paul A. Grayburn

DOI: https://doi.org/10.1016/j.jcmg.2023.12.011

2024-02-01

Abstract:BACKGROUND: Functional tricuspid regurgitation (TR) can develop either because of right ventricular (RV) remodeling (ventricular functional TR) and/or right atrial dilation (atrial functional TR).OBJECTIVES: This meta-analysis aimed to investigate the association between right heart remodeling and long-term (>1 year) all-cause mortality in patients with significant TR (at least moderate, ≥2+).METHODS: MEDLINE, ISI Web of Science, and SCOPUS databases were searched. Studies reporting data on at least 1 RV functional parameter and long-term all-cause mortality in patients with significant TR were included. This study was designed according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) requirements.RESULTS: Out of 8,902 studies, a total of 14 were included, enrolling 4,394 subjects. The duration of follow-up across the studies varied, ranging from a minimum of 15.5 months to a maximum of 73.2 months. Overall, long-term all-cause mortality was 31% (95% CI: 20%-41%; P ≤ 0.001). By means of meta-regression analyses, an inverse relation was found between tricuspid annular plane systolic excursion (11 studies enrolling 3,551 subjects, -6.3% [95% CI: -11.1% to -1.4%]; P = 0.011), RV fractional area change (9 studies, 2,975 subjects, -4.4% [95% CI: -5.9% to -2.9%]; P < 0.001), tricuspid annular dimension (7 studies, 2,986 subjects, -4.1% [95% CI: -7.6% to -0.5%]; P = 0.026), right atrial area (6 studies, 1,920 subjects, -1.9% [95% CI: -2.5% to -1.3%]; P < 0.001) and mortality.CONCLUSIONS: RV dysfunction parameters are associated to worse clinical outcomes in patients with TR, whereas right atrial dilatation is linked to a better prognostic outcome. Further studies are needed to unravel the pathophysiological differences within the functional TR spectrum. (Right heart remodeling and outcomes in patients with tricuspid regurgitation; CRD42023418667).

radiology, nuclear medicine & medical imaging,cardiac & cardiovascular systems
Implications of tricuspid regurgitation and right ventricular volume overload in patients with heart failure with preserved ejection fraction

Karl‐Patrik Kresoja,Sebastian Rosch,Anne Rebecca Schöber,Karl Fengler,Florian Schlotter,Sara Bombace,Paula Sagmeister,Maximilian von Roeder,Tobias Kister,Matthias Gutberlet,Holger Thiele,Karl‐Philipp Rommel,Philipp Lurz

DOI: https://doi.org/10.1002/ejhf.3195

2024-03-12

European Journal of Heart Failure

Abstract:Aims The aim of this study was to assess the pathophysiological implications of severe tricuspid regurgitation (TR) in patients with heart failure with preserved ejection fraction (HFpEF) by using tricuspid transcatheter edge‐to‐edge repair (T‐TEER) as a model of right ventricular (RV) volume overload relief. Methods and results This prospective interventional single arm trial (NCT04782908) included patients with invasively diagnosed HFpEF. The following parameters were prospectively assessed before and after T‐TEER: left ventricular (LV) diastolic properties by invasive pressure–volume loop recordings; biventricular time–volume curves and function as well as septal curvature by cardiac magnetic resonance imaging; strain analyses for timing of septal motion. Overall, 20 patients (median age 78, interquartile range [IQR] 72–83 years, 65% female) were included. T‐TEER reduced TR by a median of 2 (of 5) grades (IQR 2–1). T‐TEER increased LV stroke volume and LV end‐diastolic volume (LVEDV) (p

cardiac & cardiovascular systems
Abstract 11938: Mechanisms of Significant Functional Tricuspid Regurgitation in Pulmonary Arterial Hypertension

Nicholas KassisHabib LayounAmit GoyalTiffany DongAnas M SaadRishi PuriGustavo A HeresiAdriano TonelliSamir R KapadiaSerge C HarbCleveland Clinic Foundation,Cleveland,OHCLEVLAND CLINIC,Cleveland,OHCLEVELAND CLINIC,Cleveland,OH

DOI: https://doi.org/10.1161/circ.144.suppl_1.11938

IF: 37.8

2021-11-10

Circulation

Abstract:Circulation, Volume 144, Issue Suppl_1, Page A11938-A11938, November 16, 2021. Introduction:The relationship between pulmonary arterial hypertension (PAH) and secondary (or functional) tricuspid regurgitation (STR) is well-established, and the simultaneous presence of both conditions portends particularly poor outcomes. Yet not all patients with PAH develop significant STR, and the mechanisms underlying this phenomenon remain unclear.Methods:From the Cleveland Clinic Pulmonary Hypertension Registry, patients diagnosed with PAH between 2007-2013 were included. STR, defined by absent primary tricuspid valve disease on transthoracic echocardiogram (TTE), was considered significant if ≥moderate in severity (≥2+ grade) on TTE. Right-sided chambers, annular, and valvular anatomic and functional characteristics by cardiac computed tomography and TTE were compared between patients with significant vs. nonsignificant STR.Results:Among 88 included patients, 52 had significant STR. The median age was 57 years, and 78% were female. No differences were observed in all baseline clinical characteristics between groups. Relative to those with nonsignificant STR, patients with significant STR had worse right ventricular (RV) dysfunction as evidenced by lower tricuspid annular planar systolic excursion [1.5 (1.3,1.7) vs 2.1 (1.7,2.4); p=0.02] and fractional area change, and worse RV global longitudinal strain and RV free wall strain. Significant STR was further associated with increased RV sphericity as denoted by a smaller sphericity index [1.8 (1.6,2.1) vs. 2 (1.7,2.5); p=0.004], with similar annular dimensions and shape, mural and septal leaflets' length and angle, and tenting height.Conclusion:Anatomic and functional alterations in the RV rather than in the tricuspid valve are implicated in the development of STR in patients with PAH. The underlying mechanism may be linked to RV dyfunction and remodeling, via increasing RV size and sphericity.

cardiac & cardiovascular systems,peripheral vascular disease
Prognostic value of right ventricular function in patients with severe tricuspid regurgitation undergoing tricuspid valve intervention

M Bellettini,F Ancona,D Margonato,S Stella,G Ingallina,F Biondi,G Paci,C Mula,M De Bonis,P Denti,O Alfieri,A Margonato,G M De Ferrari,F Maisano,E Agricola

DOI: https://doi.org/10.1093/ehjci/jead119.352

2023-06-01

European Heart Journal - Cardiovascular Imaging

Abstract:Abstract Funding Acknowledgements Type of funding sources: None. Background Indications and optimal timing of intervention for severe tricuspid regurgitation (TR) remain controversial due to insufficient evidence. Right ventricular (RV) function assessment, a key factor of preoperative evaluation, remains challenging due to limitations of conventional echocardiographic indexes, particularly with concomitant severe TR. Right ventricular free wall longitudinal strain (RVFWLS) is able to evaluate intrinsic systolic function and to identify RV dysfunction at early stage compared to conventional echocardiographic indices. Purpose to analyze the prognostic implications of pre-operative RV dysfunction, evaluated through conventional and speckle-tracking echocardiography, in patients with severe TR undergoing tricuspid valve intervention. Methods In this single-center retrospective study, we enrolled consecutive patients with severe TR who underwent surgical or transcatheter tricuspid valve intervention (TTVI) between November 2016 and July 2021. The primary endpoint was all-cause mortality. For a secondary exploratory analysis, to compare outcomes of operated versus conservatively treated patients, we enrolled consecutive patients with severe TR who underwent echocardiographic evaluation in the same time period and who undergo conservative management. Results Study population included 100 patients: 78 patients underwent isolated TV surgical intervention and 22 TTVI. ROC curve analysis showed RVFWLS as the best echocardiographic parameter to predict all-cause mortality (AUC: 0.726, IC 0.57–0.88 P = 0.006). Estimated 4-years survival was significantly lower in patients with RV dysfunction (defined as an absolute value of RVFWLS ≤ 21%, cutoff derived from ROC analysis with sensitivity 60% and specificity 87%) compared to patients with normal RV function: 70.0% vs 93.9% p = 0.002 (Figure 1). Independent prognostic role of RVFWLS was confirmed at multivariable analysis adjusted for significative clinical and echocardiographic variables (OR 0.88, 95% CI 0.80–0.98; P = 0.016). At secondary exploratory analysis, patients treated conservatively had a worst estimated 4-year survival compared to operated patients (59.6% vs 84.0%, p = 0.001). Stratifying this population according to the presence of RV dysfunction, in the group with lower RVFWLS values there were no significative differences in overall survival between operated and conservatively-treated patients (Figure 2). Conclusions Preoperative RV dysfunction defined by echocardiographic strain analysis is independently associated with outcomes after TV intervention. RVFWLS could be useful for indication and timing of intervention for severe TR.

radiology, nuclear medicine & medical imaging,cardiac & cardiovascular systems
Natural history and mid-term prognosis of severe tricuspid regurgitation: A cohort study

Daryoush Samim,Fabien Praz,Baptiste Cochard,Nicolas Brugger,Andrea Ruberti,Joanna Bartkowiak,Noé Corpataux,David Reineke,Thomas Pilgrim,Stephan Windecker,Peter Martin Wenaweser,Mirjam G. Wild

DOI: https://doi.org/10.3389/fcvm.2022.1026230

IF: 3.6

2023-01-10

Frontiers in Cardiovascular Medicine

Abstract:Objectives: The objective of this study was to characterize a population of patients with severe tricuspid regurgitation (TR) evaluated at a tertiary care center, assess mid-term clinical outcomes, and identify prognostic factors. Background: The impact of TR on morbidity and mortality is increasingly recognized. Clinical characteristics and long-term outcomes of patients suffering from TR remain unclear. Methods: This is a retrospective observational single-center study from a tertiary care hospital including patients with echocardiographic diagnosis of severe TR between January 2017 and December 2018. We used the Kaplan–Meier method to estimate survival for up to 4 years. After excluding patients with tricuspid valve (TV) intervention and surgery during follow-up, a multivariate analysis was performed to assess predictors of 2-year mortality using the Cox regression model. Results: A total of 278 patients (mean age 74.9 ± 13.7 years, 47.8% female) with severe TR were included in the study. The majority (83.1%; n = 231) had secondary TR. Comorbidities such as atrial fibrillation (AFib) (68.0%; n = 189), severe renal failure (44.2%; n = 123), pulmonary hypertension (PHT) (80.9%; n = 225), and right ventricular (RV) dysfunction (59.7%; n = 166) were highly prevalent. More than half of patients with a cardiac implantable electronic device (CIED) (54.3%; n = 44) showed echocardiographic signs of lead-leaflet interaction causing or contributing to TR. The estimated 2- and 4-year all-cause mortality was 50 and 69%, respectively. Using multivariate analysis, age, severe renal failure, heart failure with reduced ejection fraction (HFrEF), and vena contracta width ≥14 mm were identified as predictors of 2-year mortality. Nine percent ( n = 25) of the study cohort underwent transcatheter or surgical treatment for TR during follow-up. Conclusion: Our study shows the high burden of morbidity and the dismal survival of patients with severe TR. It also highlights the extent of the therapeutic need, since the vast majority of patients were left untreated. Additionally, CIED RV lead-associated TR was prevalent suggesting a need for more attention in clinical routine and research.

cardiac & cardiovascular systems
Assessment of right ventricular function in patients with severe secondary tricuspid regurgitation, following to the TVARC recommendations: association with outcome

X Galloo,M F Dietz,E A Prihadi,F Fortuni,P Van Der Bijl,J J Bax,R T Hahn,N Ajmone Marsan

DOI: https://doi.org/10.1093/eurheartj/ehae666.1953

IF: 39.3

2024-10-30

European Heart Journal

Abstract:Introduction Severe tricuspid regurgitation (TR) is associated with increased mortality if left untreated. Recently, the Tricuspid Valve Academic Research Consortium (TVARC) has published standardized definitions of disease aetiology and severity, as well as endpoints for future clinical trials. Right ventricular (RV) function assessment represents one of the cornerstones for risk stratification in these patients, but current guidelines do not propose specific cut-off values for the echocardiographic measures. Also, the thresholds proposed by the TVARC have been derived from normative value and not yet validated in large cohorts of TR patients. Purpose To test the prognostic value of the TVARC proposed echocardiographic cut-offs for grading RV-dysfunction (figure1) in a large real-world cohort of patients with severe secondary TR (STR). Methods Consecutive patients from a single centre with first diagnosis of severe secondary STR, and without a cardiac implantable electronic device, were included. Tricuspid annulus plane systolic excursion (TAPSE), RV global and free wall strain (RVGLS and RVFWLS) and fractional area change (FAC) were used to measure RV function. The study endpoint was all-cause mortality, censored for tricuspid valve intervention. Results A total of 1043 patients (mean age 69 ± 13 years, 43% male), were included. Approximately half of the population (45%) was in NYHA class III or IV and 52% was treated with loop diuretics. Overall patients showed mild RV-dilatation (RV end-diastolic area indexed 12.2 [10.1-15.2cm2/m2]) and moderate-to-severe right atrial dilatation (right atrial maximal area indexed: 13.9 [11.0-17.5cm2/m2]). Using the proposed cut-off values, strain analysis identified a higher number of patients with impaired RV function as compared to standard echocardiographic parameters (89% based on RVGLS; 80% based on RVFWS, 61% based on TAPSE and 54% based on RVFAC). During a median follow-up of 51 [IQR 6 - 98] months, 445 (43%) patients died. The Kaplan-Meier survival curves for each echocardiographic parameter of RV-function are shown in Figure 1. TAPSE, which is the most widely used RV-function parameter, was able to clearly identify patients at high and intermediate risk when mildly, moderately and severely impaired. However, patients with normal TAPSE were still at intermediate risk when RVFWLS was (even mildly) reduced (figure 2). We therefore propose a stepwise practical approach including the measure of RVFWLS when measuring normal TAPSE, in order to possibly re-stratify patients into a higher risk group (Figure 2). This novel grading approach remained independently associated with all-cause mortality after correcting for relevant clinical and echocardiographic variables on multivariable analysis. Conclusion Novel TAVRC cut-off values for RV function show prognostic value in patients with severe STR; particularly the combination of TAPSE and RVFWLS could be use in clinical practice for risk stratification.Figure 1Figure 2

cardiac & cardiovascular systems
Right ventricular remodeling and clinical outcomes following transcatheter tricuspid valve intervention

Lyle Dershowitz,Matthew K. Lawlor,Nadira Hamid,Polydoros Kampaktsis,Yuming Ning,Torsten P. Vahl,Tamim Nazif,Omar Khalique,Vivian Ng,Paul Kurlansky,Martin Leon,Rebecca Hahn,Susheel Kodali,Isaac George

DOI: https://doi.org/10.1002/ccd.30850

IF: 2.3

2023-10-27

Catheterization and Cardiovascular Interventions

Abstract:Abstract Aims Characterize the impact of residual tricuspid regurgitation (TR) on right ventricle (RV) remodeling and clinical outcomes after transcatheter tricuspid valve intervention. Methods We performed a single‐center retrospective analysis of transcatheter tricuspid valve repair (TTVr) or replacement (TTVR) patients. The primary outcomes were longitudinal tricuspid annular plane systolic excursion (TAPSE), fractional area change (FAC), pulmonary artery systolic pressure (PASP), and RV dimensions (RVd). We used multivariable linear mixed models to evaluate association with replacement versus repair and degree of TR reduction with changes in these echo measures over time. Multivariable Cox regression was used to identify associations between changes in these echo measures and a composite clinical outcome of death, heart failure hospitalization, or re‐do tricuspid valve intervention. Results We included a total of 61 patients; mean age was 77.5 ± 11.7 and 62% were female. TTVR was performed in 25 (41%) and TTVr in 36 (59%). Initially, 72% ( n = 44) had ≤ severe TR and 28% ( n = 17) had massive or torrential TR. The median number of follow up echos was 2: time to 1st follow‐up was 50 days (interquartile range [IQR]: 20, 91) and last follow‐up was 147 (IQR: 90, 327). Median TR reduction was 1 (IQR: 0, 2) versus 4 (IQR: 3, 6) grades in TTVr versus TTVR ( p < 0.0001). In linear mixed modeling, TTVR was associated with decline in TAPSE and PASP, and TR reduction was associated with decreased RVd. In multivariable Cox regression, greater RVd was associated with the clinical outcome (hazard ratio: 9.27, 95% confidence interval: 1.23–69.88, p = 0.03). Conclusion Greater TR reduction is achieved by TTVR versus TTVr, which is in turn associated with RV reverse remodeling. RV dimension in follow‐up is associated with increased risk of a composite outcome of death, heart failure hospitalization, or re‐do tricuspid valve intervention.

cardiac & cardiovascular systems
Role of preexisting right ventricular remodeling in symptoms and prognosis after transcatheter tricuspid valve repair

Marc-André Ehrenfels,Caroline Fretter,Jennifer von Stein,Maria Isabel Körber,Hendrik Wienemann,Stephan Baldus,Roman Pfister,Christos Iliadis

DOI: https://doi.org/10.1007/s00392-024-02428-z

IF: 6.138

2024-03-07

Clinical Research in Cardiology

Abstract:Background Severe tricuspid regurgitation (TR) is associated with chronic volume overload and right ventricular remodeling (RVR). Transcatheter tricuspid valve repair (TTVr) reduces TR and can improve quality of life (QoL), but the role of preprocedural RVR on TTVr outcomes remains unclear. Aims To investigate the role of RVR on outcomes after TTVr for severe TR. Methods Consecutive patients undergoing TTVr (61% edge-to-edge vs. 39% direct annuloplasty) for severe TR were retrospectively compared by preexisting RVR which was defined as dilation of RV mid-level diameter (> 35 mm) according to guidelines. QoL was evaluated using NYHA class, Minnesota Living with Heart Failure Questionnaire (MLHFQ), 36-Item Short Form Health Survey (SF-36), and 6-min walking distance (6MWD) 1-month after TTVr. Mid-term mortality and heart failure (HF) hospitalization were assessed through 1 year. Results RVR was present in 137 of 223 patients (61%). Symptoms and QoL improved equally in both groups: ≥ 1 NYHA class (57% vs. 65% of patients with vs. without RVR, respectively), 6MWD (36% vs. 34%), MLHFQ (81% vs. 69%), and SF-36 (68% vs. 65%) improvement. One-year mortality and HF hospitalization were significantly higher in patients with RVR (24% and 30%, respectively) than in patients without (8% and 13%, both p < 0.05). In multivariable analysis, RVR was independently associated with mortality (HR 2.3, 95%CI (1.0–5.0), p = 0.04) and the combined endpoint of mortality or rehospitalization (HR 2.0, 95%CI (1.1–3.8), p = 0.03). Conclusions TTVr was associated with significant QoL improvement after 1 month, irrespective of RVR. Despite increased mortality and rehospitalization for heart failure, TTVr in the presence of RVR still provides substantial symptomatic benefit for patients with severe TR.

cardiac & cardiovascular systems
Prevalence and Prognostic Importance of Massive Tricuspid Regurgitation in Patients Undergoing Tricuspid Annuloplasty With Concomitant Left-Sided Valve Surgery: A Study on Rheumatic Valvular Heart Disease

Yan Chen,Yap-Hang Chan,Mei-Zhen Wu,Yu-Juan Yu,Yui-Ming Lam,Ko-Yung Sit,Daniel Tai-Leung Chan,Cally Ka-Lai Ho,Lai-Ming Ho,Chu-Pak Lau,Wing-Kuk Au,Hung-Fat Tse,Kai-Hang Yiu

DOI: https://doi.org/10.3389/fcvm.2022.686208

IF: 3.6

2022-01-27

Frontiers in Cardiovascular Medicine

Abstract:Background The presence of tricuspid regurgitation (TR) is very common in patients with concomitant left-sided valve disease. Recent studies have advocated an additional grading of massive TR that is beyond severe. The present study sought to characterize the spectrum of TR in patients undergoing tricuspid annuloplasty (TA) and to evaluate the prognostic value of TR severity for post-operative outcome following TA. Methods A total of 176 patients who underwent TA with combined left-sided valve surgery, secondary to rheumatic valvular heart disease, were prospectively evaluated. The severity of TR was quantified by effective regurgitant orifice area (EROA) using the proximal isovelocity surface area method. Patients were categorized as having non-massive TR (EROA < 0.6 cm 2 ) or massive TR (EROA ≥ 0.6 cm 2 ). Adverse outcome was defined as all-cause mortality or heart failure requiring hospital admission following TA. Results A total of 55 (31%) patients were considered to have massive TR. Patients with massive TR had a greater right ventricular dimension but a smaller left ventricular dimension compared with those with non-massive TR. After a median follow-up of 39 months, 35 adverse events occurred. Cox-regression analysis showed that both continuous EROA and dichotomized EROA (massive vs. non-massive TR) were independently associated with adverse events even after multivariable adjustment. Further, Harrell C index demonstrated that the addition of massive TR provided better discrimination ability of a prediction model to known prognosticators following TA. Conclusions Massive TR is common and up to 31% of study population had massive TR. Massive TR was associated with adverse outcome in patients undergoing TA. Classification of the severity of TR by quantitative measures and identification of massive TR in patients with concomitant left-sided valve disease are essential when considering the optimal timing of corrective surgery.

cardiac & cardiovascular systems

Dynamic Ontology-Based Sensor Binding

Impact of tricuspid regurgitation on right ventricular function and clinical outcomes in pulmonary arterial hypertension: food for thought

Right ventricular systolic function in severe tricuspid regurgitation: prognostic relevance of longitudinal strain

Right ventricular function in moderate-to-severe ventricular tricuspid regurgitation: Is there a pseudo-normalization of conventional echocardiographic parameters?

Prognostic Implications of Right Ventricular Remodeling and Function in Patients With Significant Secondary Tricuspid Regurgitation

Prognostic value of right atrial function in patients with significant tricuspid regurgitation

Fractionation of proteins from single neurons of Planorbis corneus by micro-electrophoresis on SDS-gradient polyacrylamide gels.

Mechanistic Insights into Tricuspid Regurgitation Secondary to Pulmonary Arterial Hypertension

Mortality and heart failure in patients with severe tricuspid regurgitation. Impact of RV volumes and function by CMR.

Experimental production of carcinoma with cigarette tar. III. Occurrence of cancer after prolonged latent period following application of tar

Impact of Right Ventricular Dysfunction and Tricuspid Regurgitation on Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement

Echocardiographic pulmonary vascular resistance in patients undergoing tricuspid annuloplasty: prognostic implications and reversibility

Right Heart Remodeling and Outcomes in Patients With Tricuspid Regurgitation

Implications of tricuspid regurgitation and right ventricular volume overload in patients with heart failure with preserved ejection fraction

Abstract 11938: Mechanisms of Significant Functional Tricuspid Regurgitation in Pulmonary Arterial Hypertension

Prognostic value of right ventricular function in patients with severe tricuspid regurgitation undergoing tricuspid valve intervention

Natural history and mid-term prognosis of severe tricuspid regurgitation: A cohort study

Assessment of right ventricular function in patients with severe secondary tricuspid regurgitation, following to the TVARC recommendations: association with outcome

Right ventricular remodeling and clinical outcomes following transcatheter tricuspid valve intervention

Role of preexisting right ventricular remodeling in symptoms and prognosis after transcatheter tricuspid valve repair

Prevalence and Prognostic Importance of Massive Tricuspid Regurgitation in Patients Undergoing Tricuspid Annuloplasty With Concomitant Left-Sided Valve Surgery: A Study on Rheumatic Valvular Heart Disease